|
US4013682A
(en)
*
|
1973-08-03 |
1977-03-22 |
Akzona Incorporated |
N-hydroxy-amidine compounds
|
|
NL7315350A
(nl)
*
|
1973-11-09 |
1975-05-13 |
Akzo Nv |
Nieuwe aminoguanidine verbindingen.
|
|
US4101675A
(en)
*
|
1973-11-09 |
1978-07-18 |
Akzona Incorporated |
Novel 2,6-di-substituted phenyl-aminoquanidine containing compositions and methods of using same and pharmaceutical compositions containing the same and therapeutic method
|
|
NL7407469A
(nl)
*
|
1974-06-01 |
1975-12-03 |
Akzo Nv |
Nieuwe amidinohydrazonverbindingen.
|
|
US5385946A
(en)
*
|
1986-07-10 |
1995-01-31 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon |
Method for treating hypertension with disubstituted granidine compounds
|
|
US5312840A
(en)
*
|
1986-07-10 |
1994-05-17 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education |
Substituted guanidines having high binding to the sigma receptor and the use thereof
|
|
US5262568A
(en)
*
|
1990-03-02 |
1993-11-16 |
State Of Oregon |
Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
|
|
US5336689A
(en)
*
|
1990-03-02 |
1994-08-09 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon |
Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
|
|
IE910719A1
(en)
|
1990-03-02 |
1991-09-11 |
Oregon State |
Tri- and tetra-substituted guanidines and their use as¹excitatory amino acid and antagonists
|
|
JPH05508836A
(ja)
*
|
1990-05-25 |
1993-12-09 |
オレゴン州 |
シグマ受容体に対して高い結合性を有する置換グアニジンおよびその使用
|
|
US5741661A
(en)
*
|
1991-02-08 |
1998-04-21 |
Cambridge Neuroscience, Inc. |
Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers
|
|
US5847006A
(en)
*
|
1991-02-08 |
1998-12-08 |
Cambridge Neuroscience, Inc. |
Therapeutic guanidines
|
|
EP0940139B1
(en)
*
|
1991-02-08 |
2005-02-02 |
Scion Pharmaceuticals, Inc. |
Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers
|
|
JP3610368B2
(ja)
*
|
1993-05-27 |
2005-01-12 |
セネス リミティド |
治療用置換グアニジン
|
|
WO1995014461A1
(en)
*
|
1993-11-23 |
1995-06-01 |
Cambridge Neuroscience, Inc. |
Therapeutic substituted guanidines
|
|
EP0738149B1
(en)
*
|
1994-01-10 |
2006-11-29 |
Teva Pharmaceutical Industries, Ltd. |
1-aminoindan derivatives and compositions thereof
|
|
US5914349A
(en)
|
1994-01-10 |
1999-06-22 |
Teva Pharmaceutical Industries, Ltd. |
Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
|
|
AU1912595A
(en)
*
|
1994-02-03 |
1995-08-21 |
Cambridge Neuroscience, Inc. |
Therapeutic guanidines
|
|
US6787569B1
(en)
|
1994-02-03 |
2004-09-07 |
Cambridge Neuroscience, Inc. |
Therapeutic guanidines
|
|
US7351743B1
(en)
|
1994-02-03 |
2008-04-01 |
Wyeth |
Therapeutic guanidines
|
|
US6143791A
(en)
*
|
1994-02-03 |
2000-11-07 |
Cambridge Neuroscience, Inc. |
Therapeutic guanidines
|
|
US6025355A
(en)
*
|
1997-05-19 |
2000-02-15 |
Cambridge Neuroscience, Inc. |
Pharmaceutically active compounds and methods of use
|
|
US6242198B1
(en)
|
1996-07-25 |
2001-06-05 |
Cambridge Neuroscience, Inc. |
Methods of treatment of eye trauma and disorders
|
|
US6756389B2
(en)
*
|
1996-08-09 |
2004-06-29 |
Cambridge Neuroscience, Inc. |
Pharmaceutically active compounds and methods of use
|
|
CA2275425C
(en)
|
1996-12-18 |
2009-08-04 |
Michael Chorev |
Aminoindan derivatives
|
|
US6737547B1
(en)
|
1998-12-31 |
2004-05-18 |
Teva Pharmaceutical Industries, Ltd. |
Compositions containing and methods of using N-acyl-1H-aminoindenes
|
|
US20040010038A1
(en)
*
|
2002-02-27 |
2004-01-15 |
Eran Blaugrund |
Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective MAO inhibitors
|
|
US20070135518A1
(en)
*
|
2005-12-09 |
2007-06-14 |
Marta Weinstock-Rosin |
Use of low-dose ladostigil for neuroprotection
|
|
JP2009518433A
(ja)
*
|
2005-12-09 |
2009-05-07 |
イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブライ ユニバーシティー オブ エルサレム |
神経保護用の低用量ラドスチギルの使用
|
|
TW200744576A
(en)
*
|
2006-02-24 |
2007-12-16 |
Teva Pharma |
Propargylated aminoindans, processes for preparation, and uses thereof
|